Rnai constructs for inhibiting pnpla3 expression and methods of use thereof
AssigneeAmgen Inc.
InventorsIngrid RULIFSON, Justin K. MURRAY, Michael OLLMANN, Oliver HOMANN
Life of this patent
Estimating the term…
Abstract
The present invention relates to RNAi constructs for reducing expression of the PNPLA3 gene. Methods of using such RNAi constructs to treat or prevent liver disease, nonalcoholic fatty liver disease (NAFLD) are also described.
Claims30
An RNAi construct comprising a sense strand and an antisense strand, wherein the antisense strand comprises a region having at least 15 contiguous nucleotides differing by no more than 3 nucleotides from an antisense sequence listed in Table 1 or 2, and wherein the RNAi construct inhibits the expression of Patatin-Like Phospholipase Domain Containing 3 (PNPLA3).
(canceled)
(canceled)
9-13. (canceled)
15-17. (canceled)
(canceled)
(canceled)
25-28. (canceled)
(canceled)
(canceled)
36-40. (canceled)
(canceled)
Dependencies are inferred from the claim text.